electroCore, Inc. (ECOR) Stock Ticker
ECOR right now
Market factors today
Unlock the full ECOR picture
About electroCore, Inc.
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
ECOR stock facts
| Ticker symbol | ECOR |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $65.2M |
| CEO | Joshua Lev |
| Employees | 83 |
| Headquarters | Rockaway, NJ, US |
| IPO date | 2018-06-22 |
| Website | www.electrocore.com |
What you can see for ECOR on Tickr
Live ECOR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ECOR report.
Rankings
FAQ
What is the ticker symbol for electroCore, Inc.?
The ticker symbol for electroCore, Inc. is ECOR, listed on the NASDAQ Capital Market.
What is ECOR?
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its…